EU unveils health technology bill

The European Commission unveiled plans for a pan-EU Health Technology Assessment (HTA) law on Wednesday (31 January), with EU health chief Vytenis Andriukaitis promising that they would help patients take advantage of “an exciting era for innovation in health”.

Supporters of biotechnology in health admit that there is still a long way to go to realise the full potential of scientific discoveries. [Tylana/Flickr]

Benjamin Fox Euractiv 31-01-2018 18:19 3 min. read Content type: Euractiv is part of the Trust Project

Donec et orci aliquet nisl suscipit molestie sed sit amet tortor. Duis vel urna ac mi sollicitudin lacinia mollis sit amet lorem. Sed finibus erat nec libero scelerisque fringilla. Morbi at orci sed urna vulputate vulputate. Nulla facilisi. Donec et orci aliquet nisl suscipit molestie sed sit amet tortor.

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro
For corporations

Commenting on the proposals, EFPIA Director General Nathalie Moll said. “Access to innovative health technologies for EU patients is a shared goal. Our healthcare systems are facing some unprecedented challenges from an ageing population and the increasing prevalence of diseases such as diabetes, cancer and dementia. Undoubtedly, the 7000 new medicines in development; new treatments like gene and cell therapies or combination therapies for patients fighting cancer will play a key role in addressing these challenges. Continued collaboration on how we introduce these new technologies into our healthcare systems will be key. HTA is an important part of that process, informing health care decision makers about the relative value of health technologies. In our view, the Commission’s proposals represent a positive, collective step forward in supporting access to new treatments for patients across Europe”.

Subscribe to our newsletters

Subscribe